Cutler Group LP Avrobio, Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 21, 2021
SELL
$12.79 - $17.1 $1,279 - $1,710
-100 Closed
0 $0
Q3 2020

Oct 27, 2020
SELL
$12.99 - $19.41 $1,299 - $1,941
-100 Reduced 50.0%
100 $1,000
Q2 2020

Jul 22, 2020
BUY
$12.19 - $22.96 $2,438 - $4,592
200 New
200 $3,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email